PE20140489A1 - Produccion de un trasplante a partir de dermis animal con disolucion de sulfuro de sodio - Google Patents
Produccion de un trasplante a partir de dermis animal con disolucion de sulfuro de sodioInfo
- Publication number
- PE20140489A1 PE20140489A1 PE2013001559A PE2013001559A PE20140489A1 PE 20140489 A1 PE20140489 A1 PE 20140489A1 PE 2013001559 A PE2013001559 A PE 2013001559A PE 2013001559 A PE2013001559 A PE 2013001559A PE 20140489 A1 PE20140489 A1 PE 20140489A1
- Authority
- PE
- Peru
- Prior art keywords
- dermis
- transplant
- production
- sodium sulfide
- treating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
- A61L27/362—Skin, e.g. dermal papillae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
- A61L27/3687—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Botany (AREA)
- Transplantation (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Cell Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Developmental Biology & Embryology (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Materials For Medical Uses (AREA)
- Prostheses (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Cosmetics (AREA)
- Treatment Of Sludge (AREA)
- Apparatus For Disinfection Or Sterilisation (AREA)
Abstract
HACE REFERENCIA A UN PROCEDIMIENTO PARA LA PRODUCCION DE UN TRASPLANTE A PARTIR DE DERMIS PORCINA, QUE COMPRENDE LAS SIGUIENTES ETAPAS: A) PROPORCIONAR DERMIS ANIMAL; B) TRATAR LA DERMIS CON UNA DISOLUCION ACUOSA QUE CONTIENE SULFURO DE SODIO EN UN VOLUMEN DE 9 A 11 VECES CON RESPECTO A LA DERMIS; C) TRATAR LA DERMIS CON UNA SOLUCION SALINA; D) TRATAR LA DERMIS CON UNA DISOLUCION ACUOSA DE PEROXIDO DE HIDROGENO; Y E) DESHIDRATAR LA DERMIS CON UN DISOLVENTE ORGANICO TAL COMO ACETONA, METANOL, ETANOL, ENTRE OTROS. DICHO PROCEDIMIENTO ES UTIL EN EL TRATAMIENTO DE HERNIAS INCISIONALES, DEHISCENCIA TRAS LAPAROTOMIA, ENTRE OTROS
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102011008604A DE102011008604A1 (de) | 2011-01-14 | 2011-01-14 | Herstellung eines Transplantats aus tierischer Dermis mit Natriumsulfidlösung |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20140489A1 true PE20140489A1 (es) | 2014-05-15 |
Family
ID=45507687
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2013001559A PE20140489A1 (es) | 2011-01-14 | 2012-01-12 | Produccion de un trasplante a partir de dermis animal con disolucion de sulfuro de sodio |
Country Status (11)
Country | Link |
---|---|
US (6) | US9814745B2 (es) |
EP (1) | EP2654815B1 (es) |
KR (1) | KR101894485B1 (es) |
CN (1) | CN103415308B (es) |
AU (1) | AU2012206763B2 (es) |
BR (1) | BR112013018037A2 (es) |
CA (1) | CA2829019A1 (es) |
DE (1) | DE102011008604A1 (es) |
PE (1) | PE20140489A1 (es) |
SG (1) | SG192729A1 (es) |
WO (1) | WO2012095316A1 (es) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20140286911A1 (en) | 2013-03-15 | 2014-09-25 | Allosource | Cell repopulated collagen matrix for soft tissue repair and regeneration |
DE102011008604A1 (de) | 2011-01-14 | 2012-07-19 | Tutogen Medical Gmbh | Herstellung eines Transplantats aus tierischer Dermis mit Natriumsulfidlösung |
US9162011B2 (en) | 2011-12-19 | 2015-10-20 | Allosource | Flowable matrix compositions and methods |
US9532866B2 (en) * | 2012-03-15 | 2017-01-03 | L&C Bio Co., Ltd. | Acellular dermal graft |
KR102277830B1 (ko) * | 2013-03-13 | 2021-07-14 | 알로소스 | 근막 섬유재 조성물 및 이들의 사용 및 제조 방법 |
DE102014102503A1 (de) * | 2014-02-26 | 2015-08-27 | Tutogen Medical Gmbh | Verfahren zur Konservierung von tierischem und insbesondere porcinem Knorpelgewebe |
WO2015138832A1 (en) | 2014-03-13 | 2015-09-17 | The General Hospital Corporation | Devices and methods to improve and assess viability of human livers |
CN104860853B (zh) * | 2015-05-20 | 2017-03-29 | 河南师范大学 | 一种对甲砜基苯丝氨酸乙酯的制备方法 |
WO2017075608A1 (en) | 2015-10-30 | 2017-05-04 | New York Society For The Relief Of The Ruptured And Crippled, Maintaining The Hospital For Special Surgery | Suture sleeve patch and methods of delivery within an existing arphroscopic workflow |
US11484401B2 (en) | 2016-02-01 | 2022-11-01 | Medos International Sarl | Tissue augmentation scaffolds for use in soft tissue fixation repair |
US20170215864A1 (en) | 2016-02-01 | 2017-08-03 | DePuy Synthes Products, Inc. | Tissue augmentation constructs for use with soft tissue fixation repair systems and methods |
FR3052669B1 (fr) | 2016-06-17 | 2018-06-15 | Meccellis Biotech | Prothese biologique destinee au traitement des hernies parastomales |
US10772986B2 (en) | 2017-01-26 | 2020-09-15 | Allosource | Fascia fibrous compositions and methods for their use and manufacture |
KR102274968B1 (ko) | 2017-12-14 | 2021-07-09 | 가이스틀리히 파마 아게 | 건조 임플란트 조성물 및 주사가능한 수성 임플란트 제형 |
US20220095607A1 (en) * | 2019-02-05 | 2022-03-31 | The General Hospital Corporation | Preservation of vascularized composite allografts |
KR102618676B1 (ko) | 2019-06-14 | 2023-12-27 | 가이스틀리히 파마 아게 | 아스코르브산을 함유하는 주사가능한 수성 임플란트 제형 |
KR102451565B1 (ko) * | 2020-07-13 | 2022-10-06 | 주식회사 엘앤씨바이오 | 수화형태 무세포화 피부대체재 및 그 제조방법 |
KR20230015191A (ko) * | 2021-07-22 | 2023-01-31 | 한스바이오메드 주식회사 | 무세포 진피층 이식재의 두께를 증가시키는 방법 |
CN115006592B (zh) * | 2022-06-15 | 2024-01-30 | 上海交通大学医学院附属第九人民医院 | 一种脱细胞真皮复合材料、制备方法及用途 |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3254938A (en) | 1962-08-29 | 1966-06-07 | Rodriguez Pedro Villa | Leather tanning |
US4801299A (en) | 1983-06-10 | 1989-01-31 | University Patents, Inc. | Body implants of extracellular matrix and means and methods of making and using such implants |
GB8413319D0 (en) | 1984-05-24 | 1984-06-27 | Oliver Roy Frederick | Biological material |
US4752347A (en) | 1986-10-03 | 1988-06-21 | Rada David C | Apparatus for preparing tissue sections |
DE3835237C1 (es) | 1988-10-15 | 1989-12-28 | B. Braun Melsungen Ag, 3508 Melsungen, De | |
US8067149B2 (en) | 1990-09-12 | 2011-11-29 | Lifecell Corporation | Acellular dermal matrix and method of use thereof for grafting |
US5507810A (en) | 1991-10-07 | 1996-04-16 | Osteotech, Inc. | Processing of fibrous connective tissue |
CN1044199C (zh) * | 1992-10-23 | 1999-07-21 | 丛培华 | 一种生物敷料的生产方法 |
DE19645107C2 (de) | 1996-11-01 | 1999-06-24 | Leica Ag | Mikrotom mit einem oszillierenden Messer |
US5993844A (en) | 1997-05-08 | 1999-11-30 | Organogenesis, Inc. | Chemical treatment, without detergents or enzymes, of tissue to form an acellular, collagenous matrix |
KR100272757B1 (ko) * | 1997-12-31 | 2000-11-15 | 서경배 | 기니픽피부디스크제조방법및이를이용한항균력측정방법 |
DE69941327D1 (de) * | 1998-02-23 | 2009-10-08 | Swift Beef Co | Verfahren und anlage zum bearbeiten von abfällen bei der enthaarung von tieren |
US6630001B2 (en) * | 1998-06-24 | 2003-10-07 | International Heart Institute Of Montana Foundation | Compliant dehyrated tissue for implantation and process of making the same |
US6267786B1 (en) | 1999-02-11 | 2001-07-31 | Crosscart, Inc. | Proteoglycan-reduced soft tissue xenografts |
DE19940426A1 (de) * | 1999-08-26 | 2001-03-01 | Tutogen Medical Gmbh | Verfahren zum Dehydratisieren von biologischen Geweben zur Herstellung von Transplantat-Konserven |
JP3865635B2 (ja) * | 2000-05-26 | 2007-01-10 | エンゲルハード・リヨン | 組織工学及び生体材料製造のためのコラーゲンベースによる支持体 |
US6696074B2 (en) | 2000-12-04 | 2004-02-24 | Tei Biosciences, Inc. | Processing fetal or neo-natal tissue to produce a scaffold for tissue engineering |
US6933103B1 (en) * | 2001-03-21 | 2005-08-23 | Brennen Medical, Inc. | Biocompatible tissue for therapeutic use and method of making same |
DE20122067U1 (de) | 2001-10-25 | 2004-02-12 | Carl Zeiss Meditec Ag | Schneidvorrichtung |
DE10217779A1 (de) | 2002-04-18 | 2003-11-13 | Co Don Ag | Konservierte Gewebematrix eines Hohlorganes, insbesondere eines Blutgefäßes, Verfahren zur Herstellung und Verwendung dieser |
US6908591B2 (en) | 2002-07-18 | 2005-06-21 | Clearant, Inc. | Methods for sterilizing biological materials by irradiation over a temperature gradient |
EP2031968B1 (en) | 2006-04-21 | 2017-11-22 | Wake Forest University Health Sciences | Structurally modified acellular tissue engineering scaffolds and methods of production |
ES2563071T3 (es) | 2007-07-10 | 2016-03-10 | Lifecell Corporation | Composiciones acelulares de matriz tisular para reparación de tejidos |
CZ301086B6 (cs) | 2007-10-17 | 2009-11-04 | Bio-Skin, A. S. | Sterilní autologní, allogenní nebo xenogenní implantát a zpusob jeho výroby |
DE102008022319A1 (de) | 2008-04-30 | 2009-11-05 | Aesculap Ag | Implantat, insbesondere zur Wiederherstellung und/oder Regenerierung von menschlichem und/oder tierischem Gewebe |
US20110177591A1 (en) | 2008-05-21 | 2011-07-21 | Tutogen Medical Gmbh | Method and device for producing dermis |
DE102011008604A1 (de) | 2011-01-14 | 2012-07-19 | Tutogen Medical Gmbh | Herstellung eines Transplantats aus tierischer Dermis mit Natriumsulfidlösung |
-
2011
- 2011-01-14 DE DE102011008604A patent/DE102011008604A1/de not_active Withdrawn
-
2012
- 2012-01-12 BR BR112013018037A patent/BR112013018037A2/pt not_active IP Right Cessation
- 2012-01-12 CN CN201280011815.9A patent/CN103415308B/zh not_active Expired - Fee Related
- 2012-01-12 WO PCT/EP2012/000124 patent/WO2012095316A1/de active Application Filing
- 2012-01-12 CA CA2829019A patent/CA2829019A1/en not_active Abandoned
- 2012-01-12 KR KR1020137021535A patent/KR101894485B1/ko active IP Right Grant
- 2012-01-12 PE PE2013001559A patent/PE20140489A1/es not_active Application Discontinuation
- 2012-01-12 SG SG2013061148A patent/SG192729A1/en unknown
- 2012-01-12 AU AU2012206763A patent/AU2012206763B2/en not_active Expired - Fee Related
- 2012-01-12 EP EP12700549.4A patent/EP2654815B1/de active Active
-
2013
- 2013-03-14 US US13/830,981 patent/US9814745B2/en active Active
- 2013-03-15 US US13/839,440 patent/US10076543B2/en active Active
-
2018
- 2018-08-27 US US16/113,951 patent/US10765703B2/en active Active
-
2020
- 2020-09-04 US US17/013,159 patent/US11382933B2/en active Active
-
2022
- 2022-06-10 US US17/838,001 patent/US11883437B2/en active Active
-
2023
- 2023-12-20 US US18/391,502 patent/US20240115621A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
US10076543B2 (en) | 2018-09-18 |
EP2654815B1 (de) | 2015-03-11 |
SG192729A1 (en) | 2013-09-30 |
WO2012095316A1 (de) | 2012-07-19 |
US11382933B2 (en) | 2022-07-12 |
US20130209572A1 (en) | 2013-08-15 |
AU2012206763B2 (en) | 2015-10-29 |
AU2012206763A1 (en) | 2013-08-29 |
US20200397829A1 (en) | 2020-12-24 |
NZ614239A (en) | 2015-03-27 |
US20220296651A1 (en) | 2022-09-22 |
BR112013018037A2 (pt) | 2019-09-24 |
US20190111087A1 (en) | 2019-04-18 |
KR20140032993A (ko) | 2014-03-17 |
KR101894485B1 (ko) | 2018-09-03 |
US20240115621A1 (en) | 2024-04-11 |
DE102011008604A1 (de) | 2012-07-19 |
US20130302436A1 (en) | 2013-11-14 |
RU2013137859A (ru) | 2015-02-20 |
US11883437B2 (en) | 2024-01-30 |
US9814745B2 (en) | 2017-11-14 |
US10765703B2 (en) | 2020-09-08 |
CN103415308A (zh) | 2013-11-27 |
CA2829019A1 (en) | 2012-07-19 |
EP2654815A1 (de) | 2013-10-30 |
CN103415308B (zh) | 2015-09-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20140489A1 (es) | Produccion de un trasplante a partir de dermis animal con disolucion de sulfuro de sodio | |
AR120961A2 (es) | Método y composición para tratar hipertensión ocular y glaucoma | |
PE20150200A1 (es) | Formulacion de anticuerpos | |
CR20160032A (es) | Compuestos de pirimidinodiona contra estados cardíacos | |
PE20141321A1 (es) | Combinaciones de principios activos | |
AR098576A1 (es) | Producto farmacéutico | |
AR078422A1 (es) | Un metodo cosmetico para la destruccion de tejido adiposo | |
CL2011001992A1 (es) | Proceso para producir 1-[2-(2,4-dimetil-fenilsulfanil)-fenil]-piperazina que comprende la etapa de precipitar el solvato isopropanol bromhidrato del compuesto a partir de un solvente con mas de 65% (v/v) de isopropanol; proceso de purificacion; y el intermediario solvato isopropanol bromhidrato del compuesto. | |
PE20121709A1 (es) | Una composicion farmaceutica para tratar cancer que comprende tripsinogeno y/o quimotripsinogeno y un agente activo seleccionado a partir de un compuesto de selenio, un compuesto vainilloide y un agente reductor de glicolisis citoplasmica | |
ECSP13012420A (es) | Derivados de tetrahidro-pirido-pirimidina | |
DOP2011000188A (es) | Compuestos de tiazolopiridinas moduladores de sirtuina | |
UY32502A (es) | Agentes antihelmínticos y su utilización | |
UY32761A (es) | Preparaciones termoestables y preparaciones insulinicas estables a las vibraciones | |
CU20130063A7 (es) | Proceso de producción de depsipéptidos cíclicos | |
BRPI0915439B8 (pt) | composição de gel tópica, bem como uso de um agente ativo para tratamento de ceratose actínica em combinação com um agente ceratoliticamente ativo para preparação da referida composição | |
UY32004A (es) | Derivados de carbamatos de alquiltiazoles, su preparación y su aplicación en terapéutica | |
CR20110660A (es) | Mezclas fungicidas | |
BR112012017994B8 (pt) | composição líquida, uso de uma composição líquida, e, métodos para preparar uma composição líquida e para tratamento de um distúrbio | |
PE20130379A1 (es) | Metodos para el tratamiento de las ulceras del pie diabetico | |
AR083249A1 (es) | Combinaciones sinergicas de triazoles, estrobirulinas y benzimidazoles, usos, formulaciones, procedimientos de produccion y aplicaciones utilizando las mismas | |
CO2021018155A2 (es) | Un derivado de tetrahidroisoquinolina sustituido como modulador alostérico positivo de d1 | |
PE20141035A1 (es) | Composiciones y metodos para tratar el cancer usando el inhibidor de pi3kbeta y el inhibidor de la via de mapk, incluidos los inhibidores de mek y raf | |
ES2673406T3 (es) | Alfa-derivados de ácidos grasos cis-monoinsaturados para uso como medicamentos en el tratamiento de la diabetes | |
AR073807A1 (es) | Proceso para preparar el malato de sunitinib, sal de un acido mas debil que el malato como compuesto intermediario, y proceso para preparar dicha sal intermediaria. | |
BR112012031014A2 (pt) | método de tratamento de biomassa de planta |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD | Application declared void or lapsed |